Top

Applied Health Economics and Health Policy

Published in:

01-09-2011 | Erratum

Erratum to: Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis

Authors: D. Mueller, A. Gandjour

Published in: Applied Health Economics and Health Policy | Issue 5/2011

Excerpt

Mueller D, Gandjour A. Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis. Appl Health Econ Health Policy 2011; 9 (4): 259–73 …

Title: Erratum to: Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis
Authors: D. Mueller
A. Gandjour
Publication date: 01-09-2011
Publisher: Springer International Publishing
Published in: Applied Health Economics and Health Policy / Issue 5/2011
Print ISSN: 1175-5652
Electronic ISSN: 1179-1896
DOI: https://doi.org/10.2165/11585610-000000000-00000

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Erratum to: Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2011

Early assessment of medical technologies to inform product development and market access

Nutrition therapy cost analysis in the US

Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE Clinical trial

Assessing quality of life among British older people using the ICEPOP CAPability (ICECAP-O) measure

Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population